81
68
Growth Score 81 in past quarter
-7 pts
Heat Score 68 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
507216
Transform Pharmaceuticals was a company specializing in the discovery of improved formulations and crystalline forms of drug molecules.
Acquired by 
Johnson & Johnson
- Nicholas Galakatos: Founder
Norman Selby: President and CEOPast Role: Citi, Executive Vice President
About the Company
Transform Pharmaceuticals was a pharmaceuticals company specializing in the discovery of improved formulations and novel crystalline forms of drug molecules.
Transform’s product portfolio included Topiramate, an anti-epileptic drug. The company was acquired by Johnson & Johnson in 2005.
The company was founded in 1998.

